1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Global Biochip Industry

Global Biochip Industry

  • February 2016
  • -
  • Global Industry Analysts
  • -
  • 292 pages

This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

 Affymetrix, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Cepheid Inc.
Fluidigm Corporation

Table Of Contents

Global Biochip Industry


I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation and Reporting Level I-2 Quantitative Techniques and Analytics I-3 Product Definitions and Scope of Study I-3 A. DNA Biochips.............. I-3 B. Protein Biochips..............I-3 C. Lab-on-a-Chip.............. I-4 D. Others.............. I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 Biochips - A Primer.............. II-1 Expanding Application Areas..............II-1 Current and Future Analysis..............II-2 DNA Biochips Lead the Application Front II-3 Protein Biochips - Set for Robust Expansion II-3 Lab-on-a-Chip: Fusion of Nanotechnology and Genetic Engineering II-4 Key Applications of Lab-on-a-Chip Technology II-4 Molecular Biology and Lab-On-A-Chip II-4 Proteomics and Lab-On-A-Chip..............II-5 Cell Biology and Lab-On-A-Chip..............II-5 Chemistry and Lab-On-A-Chip..............II-5 Growth Drivers/Market Trends..............II-5 Proteomics and Genomics Drive Demand for Biochips II-6 Growing Preference for DNA/Protein Biochips in Personalized Medicine.............. II-6 Application of Biochips in Drug Discovery - A Strong Growth Driver.............. II-7 Cancer: An Important Driver for the Biochips Market II-7 Table 1: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America and The Caribbean, and Africa (includes corresponding Graph/Chart).............. II-8

Table 2: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung and Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)..............II-9

Table 3: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung and Bronchus, and Liver Cancers (includes corresponding Graph/Chart)..............II-9 Increasing Prevalence of Lifestyle Diseases Boost Diagnostic Microarray Market.............. II-10 Table 4: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E and 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart).............. II-10

Table 5: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)..............II-11 Government Efforts to Promote Biochip Technology II-11 Integrating Tools with Diagnostic Capabilities with Smartphones - A Futuristic Trend II-12 Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics II-13 Lab-on-a-Chip System for Better Pulmonary Disease Outcome II-13 Industry Challenges.............. II-14 Standardization: A Key Challenge II-14 High Costs Restrain Growth..............II-15 Precise Protein Detection: A Challenge II-15

2. INNOVATIONS IN THE BIOCHIPS INDUSTRY II-16 Biochip Innovations in Drug Discovery Applications II-18 HuRELflow.............. II-18 MetaChip and Subsequent Versions II-18 Lab-on-a-Chip Devices in Smart Delivery of Drugs II-19 Biochips from AYOXXA: A Giant Leap in Protein Multiplexing II-19 Key Developments in the Past..............II-20

3. COMPETITION.............. II-22 Industry Structure..............II-22 Major Participants..............II-22 Affymetrix: A Pioneer Player..............II-22 Growing Partnerships between Pharma and Biotech Companies II-22 Outsourcing: A Positive Trend..............II-23

4. PRODUCT OVERVIEW.............. II-24 Biochips - Complex Blend of Biochemistry and Electronics II-24 Historical Perspective..............II-24 Promising Biochips Promote Biological Research II-25 Lab-on-a-chip: An Enabled Technology II-26 Utility.............. II-26 Evolution and Segmentation..............II-27 Differing Perspectives..............II-27 Classification of Biochips..............II-27 Need for Biochips.............. II-28 Manufacturing Systems Used in Biochip Manufacture II-29 Working of a Biochip..............II-29 DNA Transcription and Translation through A Biochip II-29 A Functional Model..............II-30 Cocktail of Disparate Technically Specialized Applications II-30 Biochips: By-product of Multi-disciplinary Sciences II-30 Nanotechnology.............. II-30 BioMEMS.............. II-30 Microfluidics.............. II-31 Micro Total Analysis System..............II-32

5. BIOCHIP AND MICROARRAY CONSTRUCTION II-33 Chip Architecture.............. II-33 Essence of a Biochip..............II-33 Concept of a Microarray..............II-33 Microarray Modules.............. II-33 High Degree of Automation Spurs Biochips Use II-34 Microfabrication Technology in Biochips made from Polymer and Plastics.............. II-34 Micro-optics in Biochips..............II-34 Liquid Handling Through Micro-Dispensers II-35 Capillary Electrophoresis and Electrochemical Detectors II-35 Other Technologies..............II-35 Management of Bio-information II-35 Scanning.............. II-36 Microarray Database Management II-36 Classification of DNA Chips..............II-36 General Description of Spotted cDNA Microarrays II-36 Spotted DNA Arrays.............. II-36 Spotted cDNA Versus Spotted Oligonucleotide Arrays II-37 Limitations of Conventional cDNA Microarrays II-37 Protein Biochips.............. II-37 General Applications of Protein Biochips: II-38 Challenges in the Design of a Protein Biochip II-38 Limitations of Protein Chip Technology II-39 Concluding Remarks for Protein Biochips II-40

6. APPLICATIONS OF BIOCHIPS..............II-41 Biochip Uses.............. II-41 Pharmaceutical Investigation..............II-42 Medical Diagnostics..............II-42 Advantages of Biosensor Chip Technology II-43 Forensics.............. II-43 Transplantation Screening..............II-43 Identity Testing.............. II-43 Water and Environmental Testing II-43 Food Industry.............. II-43

7. PRODUCT INTRODUCTIONS..............II-44 Veredus Laboratories and AVA Launch VereVet™ Lab-on-Chip Application.............. II-44 Eurofins Scientific Launches Analytical DNA Chip Technology II-44 Agilent Technologies Introduces Updated SurePrint Microarrays II-44 Agilent Technologies Launches GenetiSure Pre-Screen Microarray II-44 Agilent Technologies Launches Updates to SurePrint miRNA Microarrays.............. II-44 Clontech Laboratories Launches DNA SMART ChIP-Seq Kit II-44 PerkinElmer Launches LabChip® GX Touch Automated Electrophoresis Systems..............II-45 Cancer Genetics Launches Urogenital Cancer Array UroGenRA II-45 A STAR and Veredus Launch VereTrop™ Biochip II-45

8. RECENT INDUSTRY ACTIVITY..............II-46 Sengenics Acquires Oxford Gene Technology's Protein Array Technology.............. II-46 Immucor Acquires Sentilus..............II-46 SQI Diagnostics Expands Collaboration with Global Pharmaceutical Company..............II-46 Agenix Enters into Cross-Licensing Agreement with Arrayjet Limited.............. II-46 CombiMatrix and Manhattan Labs Enter into Distribution Partnership.............. II-46 Sequenom and CombiMatrix Enter Into Collaboration Agreement II-46

9. FOCUS ON SELECT GLOBAL PLAYERS..............II-47 Affymetrix, Inc. (US)..............II-47 Agilent Technologies, Inc. (US)..............II-47 Bio-Rad Laboratories, Inc. (US)..............II-48 Cepheid Inc. (US).............. II-49 Fluidigm Corporation (US)..............II-49 GE Healthcare Ltd. (UK)..............II-50 Hoffman-La-Roche Ltd. (Switzerland) II-50 Illumina, Inc. (US).............. II-51 Ocimum Biosolutions Ltd. (India) II-51 PerkinElmer, Inc. (US)..............II-52 Takara Bio, Inc. (Japan)..............II-52 Clontech Laboratories, Inc. (US) II-53 Thermo Fisher Scientific Inc. (US) II-53

10. GLOBAL MARKET PERSPECTIVE..............II-55 Table 6: World Recent Past, Current and Future Analysis for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. II-55

Table 7: World Historic Review for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-56

Table 8: World 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. II-57

Table 9: World Recent Past, Current and Future Analysis for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. II-58

Table 10: World Historic Review for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-59

Table 11: World 14-Year Perspective for DNA Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............II-60

Table 12: World Recent Past, Current and Future Analysis for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. II-61

Table 13: World Historic Review for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-62

Table 14: World 14-Year Perspective for Protein Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............II-63

Table 15: World Recent Past, Current and Future Analysis for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. II-64

Table 16: World Historic Review for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-65

Table 17: World 14-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............II-66

Table 18: World Recent Past, Current and Future Analysis for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. II-67

Table 19: World Historic Review for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-68

Table 20: World 14-Year Perspective for Other Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............II-69

Table 21: World Recent Past, Current and Future Analysis for Biochips by Application - Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-70

Table 22: World Historic Review for Biochips by Application - Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-71

Table 23: World 14-Year Perspective for Biochips by Application - Percentage Breakdown of Dollar Sales for Research, Diagnostics, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart) II-72

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 United States: The Global Leader for Biochips III-1 Rising Demand in Biotechnology and Life Science Research Applications.............. III-1 Lab-on-a-Chip: The Leading Segment III-2 Rapid Growth for Protein Biochips III-2 DNA Biochip Market..............III-3 Growth Drivers.............. III-3 Demand for Personalized Medicine Drives Market for Biochips III-3 Aging Population: A Strong Demographic Driver III-3 Table 24: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart) III-4

Table 25: The US Population Breakdown by Age Group (2014) (includes corresponding Graph/Chart) III-4 Growing Incidence of Cancer and Lifestyle Disorders III-5 Opportunity Indicators: Statistics Depicting Increasing Incidence of Cancer and Lifestyle Disorders III-5 Table 26: The US Cancer Incidence by Gender (2014): No. of Reported New Cases for Men and Women (includes corresponding Graph/Chart)..............III-5

Table 27: The US Cancer Incidence by Affected Site (2014): Number of New Cancer Cases (includes corresponding Graph/Chart)..............III-6

Table 28: Prevalence of Diabetes Mellitus in the US (2013 and 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for the US (includes corresponding Graph/Chart).............. III-7 Competition.............. III-7 Product Introductions..............III-7 Strategic Corporate developments III-8 Select Key Players..............III-9 B.Market Analytics..............III-15 Table 29: The US Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-15

Table 30: The US Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-16

Table 31: The US 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-17

2. CANADA.............. III-18 A.Market Analysis.............. III-18 Current and Future Analysis..............III-18 Rising Incidence of Chronic Diseases Spurs Biochips Demand III-18 Opportunity Indicators for Biochips Market: III-19 Table 32: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart) III-19 Table 33: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart) III-20 Table 34: Prevalence of Diabetes Mellitus in Canada (2013 and 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart) III-21 Strategic Corporate Development III-21 B.Market Analytics..............III-22 Table 35: Canadian Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-22

Table 36: Canadian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-23

Table 37: Canadian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-24

3. JAPAN.............. III-25 A.Market Analysis.............. III-25 Elderly Population Boosts the Biochip Market III-25 Table 38: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart) III-25 B.Market Analytics..............III-26 Table 39: Japanese Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-26

Table 40: Japanese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-27

Table 41: Japanese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-28

4. EUROPE.............. III-29 A.Market Analysis.............. III-29 Current and Future Analysis..............III-29 Leader in the DNA Biochip Segment III-29 Lab-on-chip Market in Europe III-29 European Advancements Shape Diagnostic Procedures III-30 Ageing Population Boosts Demand III-30 Table 42: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)..............III-31 Opportunity Indicator for the Biochips Market: European Personalized Medicine Market Exhibits Robust Growth III-32 Increasing Incidence of Cancer Drives Biochips Demand III-32 Table 43: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart) III-33 B.Market Analytics..............III-34 Table 44: European Recent Past, Current and Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-34

Table 45: European Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-35

Table 46: European 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............III-36

Table 47: European Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-37

Table 48: European Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-38

Table 49: European 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-39

4a. FRANCE.............. III-40 A.Market Analysis.............. III-40 Current and Future Analysis..............III-40 Product Introduction..............III-40 B.Market Analytics..............III-41 Table 50: French Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-41

Table 51: French Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-42

Table 52: French 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-43

4b. GERMANY.............. III-44 A.Market Analysis.............. III-44 Current and Future Analysis..............III-44 Berlin, Brandenburg and Biochips III-44 B.Market Analytics..............III-45 Table 53: German Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-45

Table 54: German Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-46

Table 55: German 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-47

4c. ITALY.............. III-48 A.Market Analysis.............. III-48 Current and Future Analysis..............III-48 B.Market Analytics..............III-48 Table 56: Italian Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-48

Table 57: Italian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-49

Table 58: Italian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-50

4d. THE UNITED KINGDOM..............III-51 A.Market Analysis.............. III-51 Current and Future Analysis..............III-51 Strategic Corporate development III-51 GE Healthcare Ltd. - A Key Player III-51 B.Market Analytics..............III-52 Table 59: UK Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-52

Table 60: UK Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-53

Table 61: UK 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-54

4e. SPAIN.............. III-55 Market Analysis.............. III-55 Table 62: Spanish Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-55

Table 63: Spanish Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-56

Table 64: Spanish 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-57

4f. RUSSIA.............. III-58 Market Analysis.............. III-58 Table 65: Russian Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-58

Table 66: Russian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-59

Table 67: Russian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-60

4g. REST OF EUROPE.............. III-61 Market Analysis.............. III-61 Table 68: Rest of Europe Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-61

Table 69: Rest of Europe Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-62

Table 70: Rest of Europe 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-63

5. ASIA-PACIFIC.............. III-64 A.Market Analysis.............. III-64 Increased Healthcare Spending Boosts the Biochips Market III-64 India and China Offer Significant Growth Opportunities III-64 Table 71: China and India Lead Global Population (July 2013): Table Depicting China and India's Huge Population Vis-a-vis Other Countries' Population (in Million) by Age Group (includes corresponding Graph/Chart) III-65 Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities..............III-65 Table 72: Prevalence of Diabetes Mellitus in South East Asia (2013 and 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka III-66

Table 73: Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 and 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region.............. III-67 B.Market Analytics..............III-68 Table 74: Asia-Pacific Recent Past, Current and Future Analysis for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-68

Table 75: Asia-Pacific Historic Review for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-69

Table 76: Asia-Pacific 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart) III-70

Table 77: Asia-Pacific Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-71

Table 78: Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-72

Table 79: Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-73

5a. CHINA.............. III-74 A.Market Analysis.............. III-74 Basic Environment and Commercial Development III-74 Biochip Research Institutes..............III-75 Favorable Personalized Medicine Market Boosts Demand for Biochips.............. III-75 B.Market Analytics..............III-76 Table 80: Chinese Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-76

Table 81: Chinese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-77

Table 82: Chinese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-78

5b. REST OF ASIA-PACIFIC..............III-79 A.Market Analysis.............. III-79 India: Growing Investments in Pharmacogenomics Research Drives Biochips Market..............III-79 Product Introductions..............III-79 Strategic Corporate Development III-80 Ocimum Biosolutions Ltd. - A Key India-based Player III-80 B.Market Analytics..............III-81 Table 83: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-81

Table 84: Rest of Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-82

Table 85: Rest of Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............III-83

6. LATIN AMERICA.............. III-84 Market Analysis.............. III-84 Table 86: Latin American Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-84

Table 87: Latin American Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-85

Table 88: Latin American 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-86

7. REST OF WORLD.............. III-87 Market Analysis.............. III-87 Table 89: Rest of World Recent Past, Current and Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-87

Table 90: Rest of World Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-88

Table 91: Rest of World 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. III-89

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 79 (including Divisions/Subsidiaries - 86)

The United States (45) Canada (2) Japan (6) Europe (22) - France (2) - Germany (6) - The United Kingdom (3) - Spain (2) - Rest of Europe (9) Asia-Pacific (Excluding Japan) (10) Middle East (1)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Biochip Markets: Microarrays and Lab-on-a-Chip

Global Biochip Markets: Microarrays and Lab-on-a-Chip

  • $ 6 650
  • Industry report
  • April 2016
  • by BCC Research

This BCC Research report determines the status of current and emerging biochip technologies and products and assess their worldwide growth potential over a five-year period from 2015 to 2020. The study ...

Biochips Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Biochips Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • $ 4 795
  • Industry report
  • April 2016
  • by Transparency Market Research

This market research study analyzes the biochips market on global basis and provides estimates in terms of revenue (USD million) from 2014 to 2023. It describes the market dynamics affecting the industry ...

Biochips Market by Type Lab-on-a-chip, Protein Chips, End user, Fabrication Technology - Forecast to 2020

Biochips Market by Type Lab-on-a-chip, Protein Chips, End user, Fabrication Technology - Forecast to 2020

  • $ 4 650
  • Industry report
  • May 2016
  • by MarketsandMarkets

Growing Applications of Biochips and Technological Advancements Will Boost the Growth of the Biochips Market The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.